How to buy Circassia Pharmaceuticals (CIR) shares

Learn how to easily invest in Circassia Pharmaceuticals shares.

Circassia Pharmaceuticals plc (CIR) is a publicly traded medical devices business based in the UK. It opened the day at 36.35p after a previous close of 34p. During the day the price has varied from a low of 36.18p to a high of 36.38p. The latest price was 36.3p (25 minute delay). Circassia Pharmaceuticals is listed on the London Stock Exchange (LSE) and employs 111 staff. All prices are listed in pence sterling.

How to buy shares in Circassia Pharmaceuticals

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: CIR in this case.
  5. Research Circassia Pharmaceuticals shares. The platform should provide the latest information available.
  6. Buy your Circassia Pharmaceuticals shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 500x Circassia Pharmaceuticals shares with popular platforms

Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £0.00
£181.50 total
Capital at risk
IG Share Dealing logo £0 £250 £8.00
£189.50 total
Capital at risk
Fineco logo £0 No minimum £0.00
£181.50 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £11.95
£193.45 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.78
£183.28 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £7.99
£189.49 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £9.50
£191.00 total
Capital at risk

Full comparison of share dealing platforms

Circassia Pharmaceuticals share price (LSE:CIR)

Use our graph to track the performance of CIR stocks over time.

Circassia Pharmaceuticals price performance over time

Historical closes compared with the last close of 36.3p

1 month (2022-09-02) 6.76%
3 months (2022-07-05) 15.24%
6 months (2022-04-05) 2.54%
1 year (2021-10-04) -19.15%
2 years (2020-10-05) 36.98%
3 years (2019-10-04) 128.30%
5 years (2017-10-05) -55.32%

Is it a good time to buy Circassia Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
IG bxs hero

Invest in Circassia Pharmaceuticals shares with IG

  • No commission on US shares
  • More than 13,000 shares to invest in
  • Open your account in minutes

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Circassia Pharmaceuticals under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Circassia Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Circassia Pharmaceuticals shares trade at around 34x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Circassia Pharmaceuticals shares at a glance

Information last updated 2022-09-30.
Open36.35p
High36.38p
Low36.18p
Close36.3p
Previous close34p
Change2.3p
Change %6.7647%
Volume19,554
Information last updated 2022-09-30.
52-week range29p - 49.95p
50-day moving average34.592p
200-day moving average36.5232p
Wall St. target price47p
PE ratio34
Dividend yield0p (0%)
Earnings per share (TTM)0.01p

Circassia Pharmaceuticals share dividends

We're not expecting Circassia Pharmaceuticals to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Share price volatility

Over the last 12 months, Circassia Pharmaceuticals's shares have ranged in value from as little as 29p up to 49.95p. A popular way to gauge a stock's volatility is its "beta".

CIR.LSE volatility(beta: 1.56)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Circassia Pharmaceuticals's is 1.5634. This would suggest that Circassia Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site